adenosine has been researched along with ST Elevated Myocardial Infarction in 46 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 40 (86.96) | 24.3611 |
| 2020's | 6 (13.04) | 2.80 |
| Authors | Studies |
|---|---|
| Mauro, C; Minicucci, F; Mone, P; Pansini, A; Rizzo, M | 1 |
| Aamaraee, Z; Mousavi, SH; Sadeghian, M; Shafiee, A | 1 |
| Kheifets, M; Kornowski, R; Leshem Lev, D; Perl, L; Schamroth Pravda, N; Spectre, G; Wiessman, M; Ziv, E | 1 |
| Li, X; Lv, Q; Wang, Z; Xu, S; Yao, Y | 1 |
| Abu-Zaid, E; Arseniev, L; Bauersachs, J; Chorianopoulos, E; Empen, K; Felix, SB; Ganser, A; Gawaz, MP; Greulich, S; Heuft, HG; Katus, HA; Ladage, D; Mahrholdt, H; May, AE; Meyer, GP; Müller-Ehmsen, J; Pirr, J; Ritter, B; Schultheiss, HP; Seitz, A; Tschöpe, C; Wollert, KC | 1 |
| Fischer, M; Schittek, GA; Simonis, H; Soukup, J | 1 |
| Aetesam-Ur-Rahman, M; Agrawal, BSK; Bennett, MR; Braganza, DM; Brown, AJ; Clarke, SC; Giblett, JP; Hoole, SP; Jaworski, C; West, NEJ; Zhao, TX | 1 |
| Boasi, V; Cattunar, S; Mascelli, G; Perri, D; Pistis, G; Sànchez, FA; Secco, GG; Tacchi, C; Vercellino, M | 1 |
| Buszman, P; Cook, S; Fabris, E; Kedhi, E; Kennedy, MW; van der Ent, M; von Birgelen, C; Wedel, H; Zijlstra, F | 1 |
| Chen, Q; Geng, G; Han, W; Hao, Y; Hao, Z; Jia, K; Liu, H; Liu, L; Liu, Y; Wang, D; Zhou, Y | 1 |
| Benezet, JF; Cayla, G; Ecollan, P; Hamm, CW; Hammett, CJ; Henry, P; Lapostolle, F; Lassen, JF; Montalescot, G; Stibbe, O; Storey, RF; Ten Berg, JM; Van't Hof, AW | 1 |
| Candela Sánchez, E; Carrillo Alemán, L; Esteve-Pastor, MA; Lozano, T; MacíasVillanego, MJ; Marín, F; Orenes-Piñero, E; PerniasEscrig, V; Quintana-Giner, M; Rivera-Caravaca, JM; Ruíz-Nodar, JM; Sandín Rollán, M; Tello-Montoliu, A; Valdés, M; Véliz-Martínez, A; Vicente-Ibarra, N | 1 |
| Brugaletta, S; Campo, G; Cortese, B; Geraci, S; Ielasi, A; Ishida, K; Latib, A; Nicolini, E; Poli, A; Rapetto, C; Scotto di Uccio, F; Secco, GG; Tespili, M; Varricchio, A; Vicinelli, P | 1 |
| Bagai, A; Booker, J; Cantor, WJ; Cheema, AN; Crawford, JJ; Dehghani, P; Goodman, SG; Harenberg, S; Kelly, S; Lavi, S; Lavoie, A; Mehta, SR; Zimmermann, RH | 1 |
| Alfredsson, J; Cequier, A; Chettibi, M; Goodman, SG; Janzon, M; Montalescot, G; Sederholm Lawesson, S; Swahn, E; Van't Hof, AW; Venetsanos, D | 1 |
| Adamska, U; Adamski, P; Buszko, K; Gorog, DA; Kubica, A; Kubica, J; Laskowska, E; Marszałł, MP; Navarese, EP; Ostrowska, M; Paciorek, P; Rość, D; Sikora, A; Sikora, J; Skibińska, N; Sobczak, P; Umińska, JM | 1 |
| Dudek, D; Dziewierz, A; Kleczyński, P; Plens, K; Rakowski, T; Siudak, Z | 1 |
| Bagai, A; Booker, J; Cantor, WJ; Cheema, AN; Crawford, JJ; Dehghani, P; Goodman, SG; Harenberg, S; Kelly, S; Lavi, S; Lavoie, A; Mehta, SR; Pon, Q; Yang, A; Zimmermann, RH | 1 |
| Backhaus, T; Fach, A; Fiehn, E; Garstka, D; Hambrecht, R; Schmucker, J; Stehmeier, J; Wienbergen, H | 1 |
| Alves, CMR; Berwanger, O; Bianco, HT; Caixeta, A; Carvalho, ACC; Damiani, LP; Fonseca, FAH; Fonseca, HA; França, CN; Izar, MC; Klassen, A; Maugeri, IML; Moreira, FT; Pinto, IM; Soriano Lopes, A; Szarf, G; Tavares, MFM | 1 |
| Berti, S; Bolognese, L; D'Ascenzo, F; De Luca, L; De Servi, S; Gallo, P; Granatelli, A; Gulizia, MM; Musumeci, G; Pennacchi, M; Rigattieri, S | 1 |
| Hua, J; Li, L; Wang, X; Zhang, G; Zhang, S; Zhu, L | 1 |
| Cayla, G; Collet, JP; Diallo, A; Ecollan, P; Hamm, CW; Kerneis, M; Lapostolle, F; Lattuca, B; Montalescot, G; Silvain, J; Van 't Hof, AW; Vicaut, E; Yan, Y | 1 |
| Adamski, P; Barańska, M; Buszko, K; Gorog, DA; Kubica, J; Navarese, EP; Niezgoda, P; Ostrowska, M; Paciorek, P; Sikora, J | 1 |
| Bermejo, J; Díez-Delhoyo, F; Elízaga, J; Fernández-Avilés, F; González Saldívar, H; Gutiérrez-Ibañes, E; Martínez-Sellés, M; Rivera Juárez, A; Sanz-Ruiz, R; Sarnago, F; Soriano, J; Vázquez-Álvarez, ME | 1 |
| Croce, KJ; Falcão, FC; Falcão, JL; Lemos, PA; Medeiros, F; Mont'Alverne-Filho, JR; Nicolau, JC; Rodrigues-Sobrinho, CR; Serruys, PW; Silva, RC; Valgimigli, M | 1 |
| Bernat, I; Dragounová, E; Hromádka, M; Jirouš, Š; Pechman, V; Rokyta, R; Seidlerová, J; Tůmová, P | 1 |
| Bolognese, L; Cantor, WJ; Cequier, A; Chettibi, M; Collet, JP; Goodman, SG; Hamm, CW; Hammett, CJ; Huber, K; Janzon, M; Lapostolle, F; Lassen, JF; Licour, M; Merkely, B; Montalescot, G; Salhi, N; Silvain, J; Storey, RF; Ten Berg, JM; Tsatsaris, A; van 't Hof, AW; Vicaut, E; Zeymer, U | 1 |
| Jing, Q; Li, R; Liu, P; Liu, Y; Tang, X; Wang, Q; Zhang, P | 1 |
| de Waard, GA; Diletti, R; Escaned, J; Janssens, GN; Nijveldt, R; Valgimigli, M; van der Hoeven, NW; van Leeuwen, MAH; van Royen, N; von Birgelen, C; Zijlstra, F | 1 |
| Botker, HE; Engstrom, T; Erlinge, D; Garcia-Dorado, D; Hausenloy, DJ; Heusch, G; Ibanez, B; Kloner, RA; Ovize, M; Yellon, DM | 1 |
| Baradat, C; Cayla, G; Collet, JP; Dillinger, JG; Esteve, JB; Hamm, CW; Lapostolle, F; Lassen, JF; Montalescot, G; Rousseau, H; Salhi, N; Silvain, J; Storey, RF; Ten Berg, JM; Tsatsaris, A; Van't Hof, AW | 1 |
| Baber, U; Berger, PB; Currier, J; Dave, RH; Henry, TD; Mehran, R; Nayyar, P; Rafique, AM; Tobis, J; Wang, TY | 1 |
| Blackman, D; Curzen, N; Dalby, M; Flather, M; Gershlick, AH; Greenwood, JP; Hetherington, S; Kelly, DJ; Khan, JN; Lai, FY; McCann, GP; Nazir, SA; Peebles, C; Swanton, H; Wong, J | 1 |
| Dillinger, JG; Drouet, L; Henry, P; Saeed, A; Sideris, G; Silberman, SM; Sollier, CB; Spagnoli, V; Voicu, S | 1 |
| Lozano, I; Rondan, J; Segovia, E; Vegas, JM | 1 |
| Alexopoulos, D; Antoniucci, D; Bellandi, B; Marchionni, N; Migliorini, A; Parodi, G; Scudiero, F; Valenti, R; Xanthopoulou, I; Zocchi, C | 1 |
| Cattabiani, MA; Di Vito, L; Gatto, L; Limbruno, U; Marco, V; Micari, A; Pawlowski, T; Prati, F; Romagnoli, E; Trivisonno, A; Versaci, F | 1 |
| Badimon, L; Brugaletta, S; Flores Umanzor, E; López-Lereu, MP; Muro, A; Ortiz-Pérez, JT; Sabaté, M; Sanchis, J; Vannini, L | 1 |
| Allahwala, U; Asrress, KN; Bhindi, R; Dind, A; Jolly, SS | 1 |
| Bongo, AS; De Martino, L; Lazzero, M; Lupi, A; Porto, I; Rognoni, A; Schaffer, A; Tessitori, M | 1 |
| Baek, YS; Kim, DH; Kwan, J; Kwon, SW; Lee, MJ; Park, KS; Park, SD; Shin, SH; Woo, SI | 1 |
| Brice, AE; Haynick, M; Hernandez, GA; Mendoza, CE; Sanchez, M | 1 |
| Cheema, AN; Cieza, T; Dehghani, P; Déry, JP; Fisher, HN; Goodman, SG; Henderson, MA; Kokis, A; Lavi, S; Lutchmedial, S; Mehta, SR; Siega, AJ; Welsh, RC; Wong, BY; Zhang, X; Zhu, YE | 1 |
| Di Mario, C; Sorini Dini, C; Wijns, W | 1 |
| Alves, CM; Barbosa, BR; Caixeta, A; Carvalho, AC; de Souza, CF; Falcão, F; Fonseca, FA; Généreux, P; Guimarães, LF; Pesaro, AE; Silveira, D; Stone, GW | 1 |
4 review(s) available for adenosine and ST Elevated Myocardial Infarction
| Article | Year |
|---|---|
Ticagrelor-induced thrombotic thrombocytopenic purpura: A case report and review of the literature.
Topics: ADAMTS13 Protein; Adenosine; Aged, 80 and over; Fatal Outcome; Humans; Male; Plasma Exchange; Purinergic P2Y Receptor Antagonists; Purpura, Thrombotic Thrombocytopenic; ST Elevation Myocardial Infarction; Ticagrelor; Withholding Treatment | 2018 |
Optimal P2Y12 Inhibitor in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Network Meta-Analysis.
Topics: Adenosine; Antithrombins; Bayes Theorem; Blood Platelets; Clinical Trials as Topic; Clopidogrel; Coronary Thrombosis; Drug-Eluting Stents; Evidence-Based Medicine; Hirudins; Humans; Markov Chains; Monte Carlo Method; Network Meta-Analysis; Odds Ratio; Peptide Fragments; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Recombinant Proteins; Risk Factors; ST Elevation Myocardial Infarction; Ticagrelor; Ticlopidine; Treatment Outcome | 2016 |
Contemporary Management of ST-Elevation Myocardial Infarction.
Topics: Absorbable Implants; Adenosine; Blood Vessel Prosthesis; Humans; Percutaneous Coronary Intervention; Prasugrel Hydrochloride; Purinergic P2Y Receptor Agonists; ST Elevation Myocardial Infarction; Stents; Ticagrelor | 2017 |
The year in cardiology 2016: coronary interventions.
Topics: Absorbable Implants; Acute Coronary Syndrome; Adenosine; Aftercare; Aged, 80 and over; Cardiac Imaging Techniques; Coronary Angiography; Coronary Artery Bypass; Coronary Disease; Diabetic Angiopathies; Drug Therapy, Combination; Fibrinolytic Agents; Fractional Flow Reserve, Myocardial; Graft Occlusion, Vascular; Humans; Out-of-Hospital Cardiac Arrest; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Prasugrel Hydrochloride; Prosthesis Design; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; ST Elevation Myocardial Infarction; Stents; Thrombectomy; Ticagrelor; Time-to-Treatment; Tissue Scaffolds | 2017 |
20 trial(s) available for adenosine and ST Elevated Myocardial Infarction
| Article | Year |
|---|---|
Administration of intracoronary adenosine before stenting for the prevention of no-reflow in patients with ST-elevation myocardial infarction.
Topics: Adenosine; Aged; Humans; Male; Middle Aged; No-Reflow Phenomenon; Percutaneous Coronary Intervention; ST Elevation Myocardial Infarction; Stents | 2022 |
Thrombogenicity and endothelial progenitor cells function during Acute myocardial infarction - comparison of Prasugrel versus Ticagrelor.
Topics: Adenosine; Endothelial Progenitor Cells; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; ST Elevation Myocardial Infarction; Thrombin; Ticagrelor; Treatment Outcome | 2023 |
Adenosine stress perfusion cardiac magnetic resonance imaging in patients undergoing intracoronary bone marrow cell transfer after ST-elevation myocardial infarction: the BOOST-2 perfusion substudy.
Topics: Adenosine; Aged; Bone Marrow Transplantation; Cohort Studies; Double-Blind Method; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Percutaneous Coronary Intervention; Sensitivity and Specificity; ST Elevation Myocardial Infarction; Stroke Volume; Treatment Outcome; Vasodilator Agents; Ventricular Remodeling | 2020 |
A prospective, randomized, open-label trial of 6-month versus 12-month dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction: Rationale and design of the "DAPT-STEMI trial".
Topics: Adenosine; Antithrombins; Cause of Death; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug-Eluting Stents; Europe; Follow-Up Studies; Hirudins; Peptide Fragments; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Period; Prasugrel Hydrochloride; Prospective Studies; Purinergic P2Y Receptor Antagonists; Recombinant Proteins; ST Elevation Myocardial Infarction; Survival Rate; Ticagrelor; Time Factors; Treatment Outcome | 2017 |
Short-term efficacy and safety of three different antiplatelet regimens in diabetic patients treated with primary percutaneous coronary intervention: a randomised study.
Topics: Adenosine; Aged; Aspirin; Clopidogrel; Diabetic Cardiomyopathies; Double-Blind Method; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Patient Safety; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; ST Elevation Myocardial Infarction; Ticagrelor; Ticlopidine; Tirofiban; Treatment Outcome; Tyrosine | 2017 |
Pre-hospital ticagrelor in ST-segment elevation myocardial infarction in the French ATLANTIC population.
Topics: Adenosine; Aged; Emergency Medical Services; Female; France; Humans; Male; Middle Aged; Population Surveillance; Purinergic P2Y Receptor Antagonists; ST Elevation Myocardial Infarction; Ticagrelor; Treatment Outcome | 2017 |
Effects of ticagrelor versus clopidogrel on platelet function in fibrinolytic-treated STEMI patients undergoing early PCI.
Topics: Adenosine; Blood Platelets; Clopidogrel; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Activation; Platelet Aggregation Inhibitors; Preoperative Care; Prognosis; Prospective Studies; Purinergic P2Y Receptor Antagonists; ST Elevation Myocardial Infarction; Thrombolytic Therapy; Ticagrelor; Ticlopidine; Time Factors | 2017 |
Association between gender and short-term outcome in patients with ST elevation myocardial infraction participating in the international, prospective, randomised Administration of Ticagrelor in the catheterisation Laboratory or in the Ambulance for New ST
Topics: Adenosine; Aged; Aged, 80 and over; Ambulances; Catheterization; Cause of Death; Coronary Vessels; Double-Blind Method; Emergency Medical Services; Female; Hemorrhage; Humans; International Cooperation; Male; Middle Aged; Percutaneous Coronary Intervention; Prospective Studies; Purinergic P2Y Receptor Antagonists; Sex Factors; ST Elevation Myocardial Infarction; Survival Analysis; Ticagrelor; Time-to-Treatment; Treatment Outcome | 2017 |
Long-term pharmacodynamic effects of Ticagrelor versus Clopidogrel in fibrinolytic-treated STEMI patients undergoing early PCI.
Topics: Adenosine; Aged; Clopidogrel; Female; Follow-Up Studies; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; ST Elevation Myocardial Infarction; Thrombolytic Therapy; Ticagrelor; Ticlopidine; Time Factors; Treatment Outcome | 2018 |
Effects of four antiplatelet/statin combined strategies on immune and inflammatory responses in patients with acute myocardial infarction undergoing pharmacoinvasive strategy: Design and rationale of the B and T Types of Lymphocytes Evaluation in Acute My
Topics: Adenosine; Anti-Inflammatory Agents; B-Lymphocytes; Biomarkers; Brazil; Clinical Protocols; Clopidogrel; Coronary Angiography; Drug Therapy, Combination; Enzyme-Linked Immunospot Assay; Ezetimibe; Female; Flow Cytometry; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation Mediators; Magnetic Resonance Imaging; Male; Metabolomics; Platelet Aggregation Inhibitors; Proteomics; Research Design; Rosuvastatin Calcium; Simvastatin; ST Elevation Myocardial Infarction; Stroke Volume; T-Lymphocytes; Thrombolytic Therapy; Ticagrelor; Ticlopidine; Time Factors; Treatment Outcome; Ventricular Function, Left; Ventricular Remodeling | 2017 |
Impact of age on the effect of pre-hospital P2Y12 receptor inhibition in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: the ATLANTIC-Elderly analysis
Topics: Adenosine; Aged; Double-Blind Method; Female; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Purinergic P2Y Receptor Antagonists; ST Elevation Myocardial Infarction; Treatment Outcome | 2018 |
Upstream clopidogrel, prasugrel, or ticagrelor for patients treated with primary angioplasty: Results of an angiographic randomized pilot study.
Topics: Adenosine; Aged; Angioplasty, Balloon, Coronary; Brazil; Clopidogrel; Coronary Angiography; Drug Administration Schedule; Emergency Medical Services; Female; Humans; Male; Middle Aged; Pilot Projects; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Predictive Value of Tests; Prospective Studies; ST Elevation Myocardial Infarction; Thrombectomy; Ticagrelor; Ticlopidine; Time Factors; Time-to-Treatment; Treatment Outcome | 2016 |
Effect of Pre-Hospital Ticagrelor During the First 24 h After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction: The ATLANTIC-H²⁴ Analysis.
Topics: Adenosine; Adult; Aged; Ambulances; Coronary Thrombosis; Double-Blind Method; Emergency Medical Services; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Recurrence; ST Elevation Myocardial Infarction; Ticagrelor; Time Factors; Time-to-Treatment; Treatment Outcome | 2016 |
Assessment of Ticagrelor Versus Clopidogrel Treatment in Patients With ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Topics: Adenosine; Aged; Chi-Square Distribution; China; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Odds Ratio; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Recurrence; Risk Factors; ST Elevation Myocardial Infarction; Stroke; Ticagrelor; Ticlopidine; Time Factors; Treatment Outcome | 2016 |
Reducing Microvascular Dysfunction in Revascularized Patients with ST-Elevation Myocardial Infarction by Off-Target Properties of Ticagrelor versus Prasugrel. Rationale and Design of the REDUCE-MVI Study.
Topics: Adenosine; Cardiac Catheterization; Clinical Protocols; Fractional Flow Reserve, Myocardial; Humans; Microcirculation; Myocardial Reperfusion Injury; Netherlands; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Research Design; Spain; ST Elevation Myocardial Infarction; Ticagrelor; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Vascular Resistance | 2016 |
P2Y12 receptor inhibition and effect of morphine in patients undergoing primary PCI for ST-segment elevation myocardial infarction. The PRIVATE-ATLANTIC study.
Topics: Adenosine; Blood Platelets; Combined Modality Therapy; Double-Blind Method; Drug Administration Schedule; Humans; Morphine; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; ST Elevation Myocardial Infarction; Ticagrelor | 2016 |
Infarct Size Following Treatment With Second- Versus Third-Generation P2Y12 Antagonists in Patients With Multivessel Coronary Disease at ST-Segment Elevation Myocardial Infarction in the CvLPRIT Study.
Topics: Adenosine; Aged; Clopidogrel; Coronary Angiography; Coronary Stenosis; Drug Administration Schedule; Female; Humans; Magnetic Resonance Angiography; Male; Microvessels; Middle Aged; Myocardial Revascularization; Organ Size; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Prospective Studies; Purinergic P2Y Receptor Antagonists; ST Elevation Myocardial Infarction; Ticagrelor; Ticlopidine; Time Factors; Treatment Outcome | 2016 |
Impact of oral P2Y12 inhibitors on residual thrombus burden and reperfusion indexes in patients with ST-segment elevation myocardial infarction.
Topics: Abciximab; Adenosine; Administration, Oral; Aged; Aged, 80 and over; Antibodies, Monoclonal; Clopidogrel; Coronary Angiography; Electrocardiography; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Reperfusion; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; ST Elevation Myocardial Infarction; Stents; Thrombectomy; Thrombosis; Ticagrelor; Ticlopidine; Tomography, Optical Coherence | 2016 |
Randomised trial to compare a protective effect of Clopidogrel Versus TIcagrelor on coronary Microvascular injury in ST-segment Elevation myocardial infarction (CV-TIME trial).
Topics: Adenosine; Aged; Clopidogrel; Creatine Kinase; Echocardiography; Female; Humans; Male; Microvessels; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Severity of Illness Index; ST Elevation Myocardial Infarction; Ticagrelor; Ticlopidine; Vascular Resistance | 2016 |
P2Y
Topics: Adenosine; Coronary Angiography; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Prospective Studies; Purinergic P2Y Receptor Antagonists; ST Elevation Myocardial Infarction; Thrombolytic Therapy; Ticagrelor; Time Factors; Treatment Outcome | 2017 |
22 other study(ies) available for adenosine and ST Elevated Myocardial Infarction
| Article | Year |
|---|---|
ST-Elevation Myocardial Infarction Patients with Hyperglycemia: Effects of Intravenous Adenosine.
Topics: Adenosine; Humans; Hyperglycemia; Percutaneous Coronary Intervention; ST Elevation Myocardial Infarction; Treatment Outcome | 2022 |
The impact of high on-treatment platelet reactivity and fibrinogen levels on ischemic events in patients with ST elevation myocardial infarction: a prospective observational study.
Topics: Adenosine; Aspirin; Clopidogrel; Fibrinogen; Humans; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; ST Elevation Myocardial Infarction; Ticagrelor; Ticlopidine; Treatment Outcome | 2023 |
[Severe Shock Symptoms Due to Ticagrelor Related Anaphylactoid Reaction Following ST Elevation Myocardial Infarction].
Topics: Adenosine; Aged; Humans; Male; Platelet Aggregation Inhibitors; Shock; ST Elevation Myocardial Infarction; Ticagrelor | 2019 |
Adenosine-Induced Coronary Steal Is Observed in Patients Presenting With ST-Segment-Elevation Myocardial Infarction.
Topics: Adenosine; Aged; Aged, 80 and over; Coronary Angiography; Coronary Circulation; Coronary Vessels; Electrocardiography; Female; Fractional Flow Reserve, Myocardial; Humans; Male; Microcirculation; Middle Aged; Percutaneous Coronary Intervention; ST Elevation Myocardial Infarction; Vascular Resistance | 2021 |
Ticagrelor versus clopidogrel in real-world patients with ST elevation myocardial infarction: 1-year results by propensity score analysis.
Topics: Adenosine; Aged; Clopidogrel; Coronary Angiography; Dose-Response Relationship, Drug; Electrocardiography; Female; Follow-Up Studies; Hospital Mortality; Humans; Italy; Male; Middle Aged; Platelet Aggregation Inhibitors; Propensity Score; Purinergic P2Y Receptor Antagonists; Registries; Retrospective Studies; ST Elevation Myocardial Infarction; Survival Rate; Ticagrelor; Ticlopidine; Time Factors | 2017 |
Temporal Trends in the Use of Antiplatelet Therapy in Patients With Acute Coronary Syndromes.
Topics: Acute Coronary Syndrome; Adenosine; Age Factors; Aged; Clopidogrel; Female; Hospitalization; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prasugrel Hydrochloride; Prospective Studies; Purinergic P2Y Receptor Antagonists; Registries; ST Elevation Myocardial Infarction; Ticagrelor; Ticlopidine | 2018 |
A Prospective Evaluation of a Pre-Specified Absorb BVS Implantation Strategy in ST-Segment Elevation Myocardial Infarction: The BVS STEMI STRATEGY-IT Study.
Topics: Absorbable Implants; Adenosine; Aged; Angioplasty, Balloon, Coronary; Aspirin; Coronary Thrombosis; Drug Therapy, Combination; Female; Humans; Italy; Male; Middle Aged; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Prospective Studies; Prosthesis Design; Recurrence; Risk Factors; ST Elevation Myocardial Infarction; Ticagrelor; Time Factors; Treatment Outcome | 2017 |
Comparison of bioavailability and antiplatelet action of ticagrelor in patients with ST-elevation myocardial infarction and non-ST-elevation myocardial infarction: A prospective, observational, single-centre study.
Topics: Adenosine; Aged; Biological Availability; Blood Platelets; Female; Humans; Male; Middle Aged; Non-ST Elevated Myocardial Infarction; Platelet Aggregation Inhibitors; Prospective Studies; Purinergic P2Y Receptor Antagonists; ST Elevation Myocardial Infarction; Ticagrelor | 2017 |
Contemporary use of P2Y
Topics: Adenosine; Adult; Aged; Clopidogrel; Humans; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Poland; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Registries; ST Elevation Myocardial Infarction; Ticagrelor; Ticlopidine | 2018 |
Management and predictors of outcome in unselected patients with cardiogenic shock complicating acute ST-segment elevation myocardial infarction: results from the Bremen STEMI Registry.
Topics: Adenosine; Aged; Chi-Square Distribution; Comorbidity; Drug-Eluting Stents; Female; Germany; Heart-Assist Devices; Hospital Mortality; Humans; Intra-Aortic Balloon Pumping; Logistic Models; Male; Middle Aged; Odds Ratio; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Practice Patterns, Physicians'; Prasugrel Hydrochloride; Registries; Risk Factors; Shock, Cardiogenic; ST Elevation Myocardial Infarction; Ticagrelor; Time Factors; Treatment Outcome | 2018 |
[Temporal evolution of antithrombotic therapy use in patients with acute coronary syndromes undergoing percutaneous coronary intervention in Italy: comparison between the EYESHOT and SCOPE registries].
Topics: Acute Coronary Syndrome; Adenosine; Clopidogrel; Fibrinolytic Agents; Humans; Italy; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Registries; ST Elevation Myocardial Infarction; Ticagrelor; Ticlopidine | 2018 |
Metabolism of ticagrelor in patients with acute coronary syndromes.
Topics: Acute Coronary Syndrome; Adenosine; Aged; Clinical Trials as Topic; Female; Humans; Linear Models; Male; Middle Aged; Morphine; Platelet Aggregation Inhibitors; Prospective Studies; Regression Analysis; Smoking; ST Elevation Myocardial Infarction; Ticagrelor | 2018 |
Prevalence of Microvascular and Endothelial Dysfunction in the Nonculprit Territory in Patients With Acute Myocardial Infarction.
Topics: Acetylcholine; Adenosine; Aged; Cardiac Catheterization; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Endothelium, Vascular; Female; Fractional Flow Reserve, Myocardial; Hemodynamics; Humans; Male; Microvessels; Middle Aged; Myocardial Revascularization; Prospective Studies; Spain; ST Elevation Myocardial Infarction | 2019 |
Access-site bleeding and radial artery occlusion in transradial primary percutaneous coronary intervention: influence of adjunctive antiplatelet therapy.
Topics: Abciximab; Adenosine; Aged; Antibodies, Monoclonal; Catheterization, Peripheral; Clopidogrel; Female; Hematoma; Hemorrhage; Hemostatic Techniques; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prasugrel Hydrochloride; Punctures; Purinergic P2Y Receptor Antagonists; Radial Artery; Risk Factors; ST Elevation Myocardial Infarction; Ticagrelor; Ticlopidine; Time Factors; Treatment Outcome | 2016 |
Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations.
Topics: Adenosine; Cardiotonic Agents; Clinical Trials as Topic; Combined Modality Therapy; Coronary Vessels; Cyclosporine; Enzyme Inhibitors; Humans; Hypothermia, Induced; Ischemic Postconditioning; Metoprolol; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Reperfusion; Myocardial Reperfusion Injury; Nitric Oxide; Nitrites; Nucleotides, Cyclic; Oligopeptides; Oximes; Patient Selection; Protein Kinase C; Secosteroids; Signal Transduction; ST Elevation Myocardial Infarction; Vasodilator Agents | 2017 |
High platelet reactivity on aspirin in patients with acute ST elevation myocardial infarction.
Topics: Acute Disease; Adenosine; Aspirin; Blood Platelets; Brain Ischemia; Cardiovascular Diseases; Clopidogrel; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prasugrel Hydrochloride; Prospective Studies; Purinergic P2Y Receptor Antagonists; ST Elevation Myocardial Infarction; Survival Analysis; Ticagrelor; Ticlopidine | 2016 |
Pre-Hospital Ticagrelor in ST-Segment Elevation Myocardial Infarction: Should the Hypothesis Be Re-Evaluated?
Topics: Adenosine; Electrocardiography; Humans; Myocardial Infarction; ST Elevation Myocardial Infarction; Ticagrelor | 2016 |
Morphine use and myocardial reperfusion in patients with acute myocardial infarction treated with primary PCI.
Topics: Adenosine; Aged; Analgesics, Opioid; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Morphine; Myocardial Reperfusion; Percutaneous Coronary Intervention; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prasugrel Hydrochloride; ST Elevation Myocardial Infarction; Ticagrelor; Treatment Outcome | 2016 |
Can new generation P2Y12 inhibitors play a role in microvascular obstruction in STEMI?
Topics: Adenosine; Aged; Female; Humans; Magnetic Resonance Imaging; Male; Microvessels; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; ST Elevation Myocardial Infarction; Ticagrelor | 2016 |
Pre-hospital ticagrelor in patients with ST-segment elevation myocardial infarction with long transport time to primary PCI facility.
Topics: Adenosine; Aged; Ambulances; Chi-Square Distribution; Coronary Angiography; Coronary Thrombosis; Electrocardiography; Emergency Medical Services; Female; Hemorrhage; Hospital Mortality; Humans; Italy; Kaplan-Meier Estimate; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Propensity Score; Proportional Hazards Models; Registries; Retrospective Studies; Risk Assessment; Risk Factors; ST Elevation Myocardial Infarction; Stents; Ticagrelor; Time Factors; Time-to-Treatment; Transportation of Patients; Treatment Outcome | 2016 |
In-stent thrombosis when switching ticagrelor to clopidogrel after percutaneous coronary intervention.
Topics: Adenosine; Blood Platelets; Clopidogrel; Drug Administration Schedule; Drug Dosage Calculations; Drug Substitution; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Purinergic P2Y Receptor Antagonists; ST Elevation Myocardial Infarction; Stents; Thrombosis; Ticagrelor; Ticlopidine | 2017 |
Baseline characteristics, adenosine diphosphate receptor inhibitor treatment patterns, and in-hospital outcomes of myocardial infarction patients undergoing percutaneous coronary intervention in the prospective Canadian Observational AntiPlatelet sTudy (C
Topics: Adenosine; Adult; Aged; Aged, 80 and over; Canada; Clopidogrel; Drug Substitution; Emergency Medical Services; Emergency Service, Hospital; Female; Hemorrhage; Hospitalization; Humans; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Non-ST Elevated Myocardial Infarction; Percutaneous Coronary Intervention; Prasugrel Hydrochloride; Prospective Studies; Purinergic P2Y Receptor Antagonists; ST Elevation Myocardial Infarction; Ticagrelor; Ticlopidine; Young Adult | 2016 |